Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 18.64 as of 2026-09-19T00:15:52.642Z.
Consensus retrieved: 2026-09-13T23:32:03.346Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-09-19T00:15:52.642Z.
Quote observation: 2026-09-18T20:00:03.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c92b6187e02583f105733db9e4569336ab50d6a87dd94e8abf02008e6e58d34d
Forward PE Ratio (18.64) = Dated Quote Price ($32.13) / Consensus Forward EPS ($1.72)
FORWARD PE RATIO
18.64
SECTOR MEDIAN · HEALTHCARE
18.84
median of 76 covered companies
CURRENT VS SECTOR MEDIAN
-1.09%
vs the sector median at left
Oscar Health, Inc.
Market Cap
$8.33B
Forward PE Ratio
18.64
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Oscar Health, Inc. (OSCR) | $8.33B | 18.64 |
| Henry Schein, Inc. (HSIC)vs › | $9.66B | 15.76 |
| Insulet Corp. (PODD)vs › | $9.74B | 21.62 |
| Globus Medical, Inc. (GMED)vs › | $9.99B | 14.81 |
| Chemed Corporation (CHE)vs › | $6.59B | 19.75 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.13B | 39.04 |
| The Ensign Group, Inc. (ENSG)vs › | $10.14B | 22.31 |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.24B | N/A |
| Molina Healthcare, Inc. (MOH)vs › | $10.48B | N/A |
| Align Technology, Inc. (ALGN)vs › | $10.57B | 13.07 |
Trailing P/E
22.9
reported TTM EPS
Forward P/E
18.6
consensus EPS · fiscal year ending 2026-12-31
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $1.72 implies +22.9% EPS growth vs the reported trailing $1.40.
At the dated quote price of $32.13, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $1.72 | $1.54 – $1.85 | 6 | 18.6x |
| 2027-12-31 | $1.90 | $1.45 – $2.39 | 6 | 16.9x |
| 2028-12-31 | $2.46 | $2.25 – $2.60 | 5 | 13.1x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
